Sorafenib Treatment Modalities for Hepatocellular Carcinoma Patients in Italy
Phase of Trial: Phase IV
Latest Information Update: 19 Oct 2016
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- Acronyms STELLA
- Sponsors Bayer
- 19 Oct 2016 Results (n=512) of a pooled analysis from the Italian subgroup of GIDEON and from STELLA study assessing safety and efficacy in clinical practice, presented at the 24th United European Gastroenterology Week
- 29 Jun 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 04 Mar 2014 According to ClinicalTrials.gov record, status changed from recruiting to active, no longer recruiting.